Bruker Biospin GMBH, DE | Dr. Frank Engelke |
---|---|
TavarGenix, DE | |
LifeGlimmer, DE |
Understanding metabolism in haematological cancer.
“This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 675790”.
Bruker Biospin GMBH, DE | Dr. Frank Engelke |
---|---|
TavarGenix, DE | |
LifeGlimmer, DE |